Introduction

The U.S. is a global leader in biopharmaceutical innovation and manufacturing. The industry, however, faces pressures from different directions with implications for the pace of drug development, the price of medicines and the relationship between the pharmaceutical industry, regulators, patient advocates and the public. At the same time, new technological advancements such as artificial intelligence hold lots of promise for the sector.

This four-part series will examine the interplay between those factors and how they are driving the medical world into the future. We’ll also have a podcast to accompany each issue, so be sure to tune in to The Daily Punch each week.

In this series, we’ll look into:

• The State of Play: an overview of the state of the life sciences industry and the factors driving it into the future
• The Legislative Landscape: How the industry is navigating key rules and legislating actions that would impact the drug development process
• A Leading Voice: A key lawmaker will provide important insight into how Congress is approaching the issue
• The Players: the main people and institutions influencing the future of medicine